2023 annual financial data
Zevra Therapeutics 2023 Operating margin
Direct answer
Operating margin was -180.63%.
Operating income was -49,604,000 USD and net income was -46,049,000 USD.
Operating cash flow was -33,535,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,461,000 USD
- Operating income
- -49,604,000 USD
- Net income
- -46,049,000 USD
- Operating cash flow
- -33,535,000 USD